0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug Therapy
 301-320 of 613 Articles
Viewpoint | 
Leo Beletsky, JD, MPH; Josiah D. Rich, MD, MPH; Alexander Y. Walley, MD, MSc
JAMA. 2012;308(18):1863-1864. doi:10.1001/jama.2012.14205.

Viewpoint | 
G. Caleb Alexander, MD, MS; Stefan P. Kruszewski, MD; Daniel W. Webster, ScD, MPH
JAMA. 2012;308(18):1865-1866. doi:10.1001/jama.2012.14282.

From the Centers for Disease Control and Prevention |  FREE
JAMA. 2012;308(18):1850-1853. doi:10.1001/2012.jama.11292.

Grand Rounds | 
Nancy A. Rigotti, MD
JAMA. 2012;308(15):1573-1580. doi:10.1001/jama.2012.13043.
Includes: CME

Research Letters |  FREE
Jeffery Talbert, PhD; Karen Blumenschein, PharmD; Amy Burke, PhD; et al.
JAMA. 2012;308(15):1524-1526. doi:10.1001/jama.2012.12992.

Capitol Health Call | 
Mike Mitka, MSJ
JAMA. 2012;308(14):1421. doi:10.1001/jama.2012.12713.

Capitol Health Call | 
Mike Mitka, MSJ
JAMA. 2012;308(14):1421. doi:10.1001/jama.2012.13452.

Research Letters |  FREE
Emily Dodwell, MD, MPH; Brian Snyder, MD, PhD; James Wright, MD, MPH
JAMA. 2012;308(14):1429-1432. doi:10.1001/jama.2012.12929.

Viewpoint | 
Robert Steinbrook, MD; Joshua M. Sharfstein, MD
JAMA. 2012;308(14):1437-1438. doi:10.1001/jama.2012.12829.

Viewpoint | 
Jonathan M. Davis, MD; Edward M. Connor, MD, MBE; Alastair J. J. Wood, MB, ChB
JAMA. 2012;308(14):1435-1436. doi:10.1001/jama.2012.12883.

Lab Reports | 
Tracy Hampton, PhD
JAMA. 2012;308(13):1310. doi:10.1001/jama.2012.12679.

Medical News and Perspectives | 
Bridget M. Kuehn
JAMA. 2012;308(13):1307. doi:10.1001/jama.2012.13019.

Users' Guides to the Medical Literature | 
Edward J. Mills, PhD, MSc; John P. A. Ioannidis, MD, DSc; Kristian Thorlund, PhD, MSc; et al.
JAMA. 2012;308(12):1246-1253. doi:10.1001/2012.jama.11228.
Includes: Supplemental Content

Viewpoint | 
Elaine H. Morrato, DrPH, MPH; David B. Allison, PhD
JAMA. 2012;308(11):1097-1098. doi:10.1001/jama.2012.10007.

Capitol Health Call | 
Mike Mitka
JAMA. 2012;308(10):964. doi:10.1001/2012.jama.11530.

Research Letters |  FREE
Jeremy A. Greene, MD, PhD; Niteesh K. Choudhry, MD, PhD; Aaron S. Kesselheim, MD, JD, MPH; et al.
JAMA. 2012;308(10):973-975. doi:10.1001/2012.jama.10647.

Medical News and Perspectives | 
Tracy Hampton, PhD
JAMA. 2012;308(9):850-851. doi:10.1001/2012.jama.10451.

Viewpoint | 
Thomas J. Moore, AB; Curt D. Furberg, MD, PhD
JAMA. 2012;308(9):869-870. doi:10.1001/jama.2012.9658.

Viewpoint | 
Marc A. Rodwin, JD, PhD; John D. Abramson, MD, MS
JAMA. 2012;308(9):871-872. doi:10.1001/jama.2012.9661.

Medical News and Perspectives | 
Bridget M. Kuehn
JAMA. 2012;308(8):749-750. doi:10.1001/jama.2012.9289.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Psychiatry
Original Investigation  | 
Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia: A Prospective Dopamine D2/3 Receptor Occupancy Study
Ariel Graff-Guerrero, MD, PhD; Tarek K. Rajji, MD; Benoit H. Mulsant, MD, MS; et al.
JAMA Internal Medicine
Invited Commentary  | 
Effects of Excessive Antibiotic Use in Nursing Homes
Lona Mody, MD, MSc; Christopher Crnich, MD, PhD
JAMA Internal Medicine
Original Investigation  | 
Efficacy of Grass Pollen Allergen Sublingual Immunotherapy Tablets for Seasonal Allergic Rhinoconjunctivitis: A Systematic Review and Meta-analysis
Danilo Di Bona, MD, PhD; Antonella Plaia, PhD; Maria Stefania Leto-Barone, MD, PhD; et al.
JAMA Psychiatry
Original Investigation  | 
Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia : A Randomized Clinical Trial
Kenneth L. Subotnik, PhD; Laurie R. Casaus, MD; Joseph Ventura, PhD; et al.